hereditary angiodema

ADARx secures $200m to advance clinical programs
Pharmaceutical Technology
Thu, 08/10/23 - 10:08 am
ADARx Pharmaceuticals
funding
ADX-324
hereditary angiodema
Patients attack-free a year after receiving Intellia's hereditary angioedema CRISPR med
Fierce Biotech
Sun, 06/11/23 - 11:07 pm
Intellia Therapeutics
HAE
hereditary angiodema
CRISPR
NTLA-2002
Ionis presents positive Phase 2 data from open label extension study of donidalorsen at 2022 ACAAI Annual Meeting
Yahoo Finance
Sun, 11/13/22 - 06:59 pm
Ionis Pharmaceuticals
clinical trials
donidalorsen
hereditary angiodema
HAE
KalVista ends a PhII study early after patients suffer severe and life-threatening side effects
Endpoints
Tue, 10/4/22 - 11:37 pm
KalVista
KVD824
clinical trials
hereditary angiodema
Intellia's Latest Data Indicate Full Potential of CRISPR
BioSpace
Sun, 09/18/22 - 10:31 pm
Intellia Therapeutics
ATTR amyloidosis
hereditary angiodema
CRISPR
Pharvaris studies of rare disease drug put on hold by FDA
BioPharma Dive
Mon, 08/22/22 - 08:12 pm
Pharvaris
FDA
hereditary angiodema
HAE
PHA121
CSL reports Phase III data for garadacimab to treat hereditary angioedema
Clinical Trials Arena
Thu, 08/18/22 - 12:30 pm
CSL
clinical trials
garadacimab
HAE
hereditary angiodema
Takeda, CSL hereditary angioedema meds need steep discounts following real-world evidence review, ICER says
Fierce Pharma
Wed, 08/25/21 - 09:32 pm
Takeda
CSL
hereditary angiodema
HAE
RWE
Takhzyro
Cinryze
Haegarda
Ionis unveils positive PhII data for in-house rare disease drug, paving way to blockbuster rivalry with Takeda
Endpoints
Mon, 03/29/21 - 10:52 pm
Ionis Pharmaceuticals
clinical trials
IONIS-PKK-LRx
hereditary angiodema
Mid-stage angioedema hit sends Kalvista though the roof
EP Vantage
Tue, 02/9/21 - 11:23 am
KalVista
HAE
hereditary angiodema
KVD900
Cost-effectiveness doubts could hit Shire’s Takhzyro launch
EP Vantage
Fri, 10/12/18 - 11:43 pm
Shire
Cinryze
Takhzyro
drug pricing
hereditary angiodema
BioCryst says oral drug works for HAE attacks
Fierce Biotech
Tue, 09/4/18 - 11:02 am
Biocryst
BCX7353
clinical trials
HAE
hereditary angiodema
Shire Secures FDA Approval for HAE Drug Lanadelumab
BioSpace
Fri, 08/24/18 - 11:23 am
Shire
Takeda
HAE
hereditary angiodema
Takhzyro
lanadelumab
FDA
Adverum Biotechnologies Receives Orphan Drug Designation for Hereditary Angioedema Gene Therapy Candidate
CP Wire
Fri, 08/24/18 - 11:00 am
Adverum Biotechnologies
ADVM-053
hereditary angiodema
HAE
FDA
Adverum Biotechnologies Receives Orphan Drug Designation for Hereditary Angioedema Gene Therapy Candidate
Fri, 08/24/18 - 09:50 am
Adverum Biotechnologies
ADVM-053
hereditary angiodema
Shire says trial shows new HAE drug significantly reduces attacks
Reuters
Tue, 09/12/17 - 10:15 am
Shire
HAE
clinical trials
hereditary angiodema
SHP616
FDA OKs CSL’s new HAE drug, already embroiled in a blockbuster fight with Shire
Endpoints
Fri, 06/23/17 - 09:48 am
FDA
CSL
HAE
hereditary angiodema
Shire
Haegarda
Firazyr
Kalbito
Shire, armed with new rare disease patent, aims to block CSL's Haegarda launch
Fierce Pharma
Mon, 04/17/17 - 04:10 pm
Shire
rare disease
CSL
patents
Haegarda
HAE
hereditary angiodema
How Does Shire Lead the Angioedema Space?
Yahoo/Market Realist
Wed, 04/27/16 - 09:08 am
Shire
Cinryza
Firazyr
HAE
hereditary angiodema
Dyax banks on drug designation news
Bizjournals.com
Tue, 07/7/15 - 12:28 pm
Dyax
DX-2930
HAE
hereditary angiodema

Pages